CompanyTrack
P

PILL CONNECT LIMITED

Active Manchester

Other research and experimental development on natural sciences and engineering

5 employees Website
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
P

PILL CONNECT LIMITED

Other research and experimental development on natural sciences and engineering

Founded 7 Oct 2013 Active Manchester, England 5 employees pillconnect.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
Accounts Submitted 17 Jul 2025
Confirmation Statement Submitted 6 Oct 2025
Net assets £101.11K £55.58K 2024 year on year
Total assets £0.00 £189.56K 2024 year on year
Total Liabilities £29.90K £2.97K 2024 year on year
Charges 1
1 satisfied

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

125 Deansgate Manchester Greater Manchester M3 2BY England

Credit Report

Discover PILL CONNECT LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£47.00k

Decreased by £57.37k (-55%)

Net Assets

£101.11k

Decreased by £55.58k (-35%)

Total Liabilities

£29.90k

Decreased by £2.97k (-9%)

Turnover

N/A

Employees

5

Debt Ratio

N/A

Decreased by 17 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

6 active 4 resigned
Status
Carl William BarrattDirectorBritishEngland5412 Mar 2021Active
Christopher Maxwell HallDirectorBritishEngland5912 Mar 2021Active
Ian Geoffrey SmithDirectorBritishEngland778 Dec 2016Active
James BurnstoneDirectorBritishEngland378 Dec 2016Active
Naseeb SinghDirectorBritishEngland421 Oct 2025Active
Richard Henry SmithDirectorEnglishEngland5731 Aug 2017Active

Shareholders

Shareholders (18)

The Gm & Cheshire Life Sciences Fund L.p
39.0%
2,217,6116 Oct 2025
Shallcross Partners Ltd
1.5%
83,3126 Oct 2025
Wcs Nominees Limited
0.0%
2,6636 Oct 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active 4 Ceased

Catapult Venture Managers Limited

United Kingdom

Active
Notified 1 Sept 2017
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Graham Howieson

Ceased 9 Oct 2020

Ceased

Catapult Life Sciences Gp Llp

Ceased 12 Oct 2023

Ceased

Mohammad Farid Khan

Ceased 9 Oct 2020

Ceased

Catapult Venture Managers Limited

Ceased 29 Aug 2023

Ceased

Group Structure

Group Structure

CATAPULT VENTURE MANAGERS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors, significant influence or control
CATAPULT ULTIMATE HOLDINGS LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent
SLINGSHOT BUYOUT LIMITED united kingdom
BW SIPP TRUSTEES LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors, appoint/remove directors as trust, appoint/remove directors as firm
BARNETT WADDINGHAM LLP united kingdom significant influence or control limited liability partnership
HOWDEN UK&I HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
HOWDEN BROKING GROUP LIMITED united kingdom shares 75 to 100 percent
HYPERION DEVELOPMENT UK LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
HGH MIDCO 3 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
HGH FINANCE LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
HIG FINANCE 2 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
HGH MIDCO 2 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
HGH MIDCO 1 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
PILL CONNECT LIMITED Current Company

Charges

Charges

1 satisfied

Documents

Company Filings

DateCategoryDescriptionDocument
20 Oct 2025OfficersChange to director Sim Singh-Landa on 2025-10-01View(2 pages)
7 Oct 2025OfficersAppointment of Sim Singh-Landa as director on 2025-10-01View(2 pages)
6 Oct 2025Confirmation StatementConfirmation statement made on 2025-09-24 with updatesView(6 pages)
17 Jul 2025AccountsAnnual accounts made up to 2024-10-31View(8 pages)
17 Feb 2025CapitalAllotment of shares (GBP 568.7913) on 2025-01-16View(6 pages)
20 Oct 2025 Officers

Change to director Sim Singh-Landa on 2025-10-01

7 Oct 2025 Officers

Appointment of Sim Singh-Landa as director on 2025-10-01

6 Oct 2025 Confirmation Statement

Confirmation statement made on 2025-09-24 with updates

17 Jul 2025 Accounts

Annual accounts made up to 2024-10-31

17 Feb 2025 Capital

Allotment of shares (GBP 568.7913) on 2025-01-16

Recent Activity

Latest Activity

Change to director Sim Singh-Landa on 2025-10-01

3 months ago on 20 Oct 2025

Appointment of Sim Singh-Landa as director on 2025-10-01

4 months ago on 7 Oct 2025

Confirmation statement made on 2025-09-24 with updates

4 months ago on 6 Oct 2025

Annual accounts made up to 2024-10-31

7 months ago on 17 Jul 2025

Allotment of shares (GBP 568.7913) on 2025-01-16

12 months ago on 17 Feb 2025